Literature DB >> 25306931

Effects of early morning care, named "Comfort upon Rising" care, on postoperative orthopedic ambulation and morning activity.

Kumiko Ohashi1.   

Abstract

AIM: To examine the effects of "Comfort upon Rising" care (CUR) as a new type of early morning care.
METHODS: This was a quasi-experimental study using a convenience sampling and non-random assignment of 80 orthopedic postoperative inpatients needing ambulation assistance. The intervention group of 40 inpatients was given CUR designed to support the patients' needs. The control group of 40 inpatients was given conventional early morning care (CMC). Floor nurses conducted either CMC or CUR for subjects beginning the morning after surgery and continuing for 3 days. Mood was measured by the Wake-up Questionnaire (question I) and Profile of Mood States (POMS). Morning activities, which were daily living activities, breakfast behaviors including breakfast intake rate, were measured by Wake-up Questionnaire (question IV) and observation.
RESULTS: Completing the study were 36 patients from the control group and 36 patients from the intervention group. Mood and activities in the morning were improved in the CUR group.
CONCLUSION: CUR is a patient-centered care based on patients' individual needs and promotes self-care. CUR is more effective than CMC in promoting natural recovery after an operation.
© 2013 The Author. Japan Journal of Nursing Science © 2013 Japan Academy of Nursing Science.

Entities:  

Keywords:  activity; early morning care; patient-centered care; postoperative; recovery

Mesh:

Year:  2013        PMID: 25306931     DOI: 10.1111/jjns.12028

Source DB:  PubMed          Journal:  Jpn J Nurs Sci        ISSN: 1742-7924            Impact factor:   1.418


  1 in total

1.  Effect of comfort nursing on postoperative quality of life, negative emotions and nursing satisfaction in patients undergoing laparoscopic surgery.

Authors:  Yuan Gao; Jing Huang; Yan Zheng; Jiacen Han
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.